Göbel A - Search Results

1

Potentiated suppression of Dickkopf-1 in breast cancer by combined administration of the mevalonate pathway inhibitors zoledronic acid and statins.

Göbel A, Browne AJ, Thiele S, Rauner M, Hofbauer LC, Rachner TD. Göbel A, et al. Breast Cancer Res Treat. 2015 Dec;154(3):623-31. doi: 10.1007/s10549-015-3624-8. Epub 2015 Oct 29. Breast Cancer Res Treat. 2015. PMID: 26515701

2

Dickkopf-1 as a mediator and novel target in malignant bone disease.

Rachner TD, Göbel A, Benad-Mehner P, Hofbauer LC, Rauner M. Rachner TD, et al. Among authors: gobel a. Cancer Lett. 2014 May 1;346(2):172-7. doi: 10.1016/j.canlet.2014.01.010. Epub 2014 Jan 22. Cancer Lett. 2014. PMID: 24462802 Review.

3

Dickkopf-1 is regulated by the mevalonate pathway in breast cancer.

Rachner TD, Göbel A, Thiele S, Rauner M, Benad-Mehner P, Hadji P, Bauer T, Muders MH, Baretton GB, Jakob F, Ebert R, Bornhäuser M, Schem C, Hofbauer LC. Rachner TD, et al. Among authors: gobel a. Breast Cancer Res. 2014 Feb 14;16(1):R20. doi: 10.1186/bcr3616. Breast Cancer Res. 2014. PMID: 24528599 Free PMC article.

4

High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients.

Rachner TD, Thiele S, Göbel A, Browne A, Fuessel S, Erdmann K, Wirth MP, Fröhner M, Todenhöfer T, Muders MH, Kieslinger M, Rauner M, Hofbauer LC. Rachner TD, et al. Among authors: gobel a. BMC Cancer. 2014 Sep 2;14:649. doi: 10.1186/1471-2407-14-649. BMC Cancer. 2014. PMID: 25182503 Free PMC article.

5

WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo.

Thiele S, Göbel A, Rachner TD, Fuessel S, Froehner M, Muders MH, Baretton GB, Bernhardt R, Jakob F, Glüer CC, Bornhäuser M, Rauner M, Hofbauer LC. Thiele S, et al. Among authors: gobel a. J Bone Miner Res. 2015 Mar;30(3):471-80. doi: 10.1002/jbmr.2362. J Bone Miner Res. 2015. PMID: 25224731 Free article.

6

P38 regulates the Wnt inhibitor Dickkopf-1 in breast cancer.

Rachner TD, Göbel A, Browne A, Hötzel J, Rauner M, Hofbauer LC. Rachner TD, et al. Among authors: gobel a. Biochem Biophys Res Commun. 2015 Oct 30;466(4):728-32. doi: 10.1016/j.bbrc.2015.09.101. Epub 2015 Sep 25. Biochem Biophys Res Commun. 2015. PMID: 26407843

7

Regulation of VEGF by mevalonate pathway inhibition in breast cancer.

Rachner TD, Göbel A, Junker M, Hötzel J, Benad-Mehner P, Hadji P, Hofbauer LC. Rachner TD, et al. Among authors: gobel a. J Bone Oncol. 2013 Jun 7;2(3):110-5. doi: 10.1016/j.jbo.2013.05.003. eCollection 2013 Sep. J Bone Oncol. 2013. PMID: 26909280 Free PMC article.

8

Targeting syndecan-1 in breast cancer inhibits osteoclast functions through up-regulation of osteoprotegerin.

Benad-Mehner P, Thiele S, Rachner TD, Göbel A, Rauner M, Hofbauer LC. Benad-Mehner P, et al. Among authors: gobel a. J Bone Oncol. 2013 Nov 15;3(1):18-24. doi: 10.1016/j.jbo.2013.11.001. eCollection 2014 Mar. J Bone Oncol. 2013. PMID: 26909290 Free PMC article.

9

Zoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cells.

Wilke M, Göbel A, Rauner M, Benad-Mehner P, Schütze N, Füssel S, Hadji P, Hofbauer LC, Rachner TD. Wilke M, et al. Among authors: gobel a. J Bone Oncol. 2014 Feb 18;3(1):10-7. doi: 10.1016/j.jbo.2014.02.001. eCollection 2014 Mar. J Bone Oncol. 2014. PMID: 26909293 Free PMC article.

10

p38 MAPK regulates the Wnt inhibitor Dickkopf-1 in osteotropic prostate cancer cells.

Browne AJ, Göbel A, Thiele S, Hofbauer LC, Rauner M, Rachner TD. Browne AJ, et al. Among authors: gobel a. Cell Death Dis. 2016 Feb 25;7(2):e2119. doi: 10.1038/cddis.2016.32. Cell Death Dis. 2016. PMID: 26913608 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters